This website uses cookies to improve your experience on the site. By continuing to use this site, you agree to the use of cookies. To learn more about how we use cookies, please see our Cookie Policy.

Compliance with FDA Labeling Guidelines No Defense Against Federal Unfair Competition Claims

June 11, 2014

In a highly-anticipated decision, the United States Supreme Court announced today that compliance with the Food and Drug Administration’s food labeling guidelines is no defense against unfair competition claims brought by competitors under the Lanham Act. Quite the contrary – the Court found today, in the case of POM Wonderful LLC v. Coca-Cola Co., "powerful evidence that Congress did not intend FDA oversight to be the exclusive means of ensuring proper food and beverage labeling."